Press Releases April 20, 2026 12:07 PM

Saia Expands Northeast Network with New Terminal in Pennsylvania

Saia Inc. expands its Northeast network with a new terminal in York, Pennsylvania to improve service capacity and transit times.

By Ajmal Hussain
Share
Twitter Reddit Facebook LinkedIn
SAIA

Saia Inc., a leading US less-than-truckload transportation provider, has opened a new terminal in York, Pennsylvania, enhancing capacity with 74 doors. This strategic expansion strengthens Saia's coverage in the Northeast, aiming to support increased shipment volumes and improve transit times and reliability for customers in central Pennsylvania and adjacent markets.

Saia Expands Northeast Network with New Terminal in Pennsylvania
SAIA
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Saia opened a new 74-door terminal in York, Pennsylvania to expand Northeast network.
  • The facility aims to improve transit times, service reliability, and shipment capacity in central Pennsylvania and surrounding areas.
  • This expansion supports Saia's strategy to grow its nationwide footprint and serve key distribution corridors in the Mid-Atlantic and Northeast regions.

JOHNS CREEK, Ga., April 20, 2026 (GLOBE NEWSWIRE) -- Saia Inc. (NASDAQ: SAIA) a leading provider of less-than-truckload (LTL) transportation services, announced the opening of its newest terminal in York, Pennsylvania, further enhancing the company’s growing network in the Northeast. The new facility commenced operations today.

The York terminal features 74 doors, expanding Saia’s capacity to support increased shipment volumes while improving transit times and service reliability for customers throughout central Pennsylvania and surrounding markets.

“Expanding our network in key markets like York allows us to better serve our customers with the speed, reliability and flexibility they expect from Saia,” said Saia Executive Vice President of Operations Patrick Sugar. “This new facility strengthens our Northeast coverage and positions us to support continued growth across the region.”

Strategically located to serve one of Pennsylvania’s key distribution corridors, the York terminal enhances connectivity between major metropolitan areas in the Mid-Atlantic and Northeast. The additional capacity will enable more efficient freight movement while supporting local and regional businesses with dependable LTL service.

The opening of the York facility reflects Saia’s ongoing commitment to thoughtfully expanding its nationwide network to meet customer demand and deliver best-in-class service.

For more information about Saia and its freight and logistics capabilities, visit Saia.com.

About Saia Inc.

Saia Inc. (NASDAQ: SAIA) is a full-service freight and logistics provider with a national footprint built to deliver reliable, flexible shipping solutions. With industry-leading operations and a strong emphasis on the customer experience, the company helps keep freight - and businesses - moving. Saia offers customers a wide range of less-than-truckload, non-asset truckload, expedited, and logistics services. Headquartered in Johns Creek, Georgia, the company operates 214 terminals across the country. Saia has repeatedly been recognized for its people-centric, safety-driven, and sustainability-minded focus. For more information on Saia Inc., visit Saia.com.

For more information, contact:
Jeannie S. Jump
Senior Marketing and Corporate Affairs Specialist
Phone: 770-232-4069 Email: [email protected] 


Risks

  • Expansion may involve increased operational costs and capital expenditure impacting financial performance.
  • Potential risks related to demand fluctuations in freight volumes affecting terminal utilization.
  • Integration challenges or delays in realizing operational efficiencies at the new facility may impact expected service improvements.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026